Basketball
Bacolod has been fined ₱500,000 for forfeiting their game against Pangasinan on June 21, 2025, during the Manny Pacquiao Presents 1xBet–MPBL 2025 Season at...
Hi, what are you looking for?
For the second time in her career, Alex Eala has defeated a current World No. 2. Eala found the antidote to Elena Rybakina’s power,...
Italy averted a massive meltdown and denied fellow European side Serbia in a thrilling 25–14, 25–15, 18–25, 21–25, 15–12 marathon to keep its Week...
Scottie Thompson’s eyes widened upon hearing the announcement that he was hailed as the PBA Press Corps Finals MVP on the heels of Barangay...
Mike Phillips can still vividly remember the first time he got the call-up to serve the country. Back in 2023, Phillips — then entering...
Bacolod has been fined ₱500,000 for forfeiting their game against Pangasinan on June 21, 2025, during the Manny Pacquiao Presents 1xBet–MPBL 2025 Season at...
Adamson University finally barged into the win column of the Playtime Cares Filoil 18th Preseason Cup presented by ABC Tile Adhesive after outlasting University...
VIGAN, ILOCOS SUR — Heather Guino-o made an immediate impact in her debut for Cignal, relying on her familiarity with head coach Shaq Delos...
VIGAN, ILOCOS SUR — Cignal sustained its fine start to the 2025 PVL On Tour, making it two consecutive victories with a commanding 25-21,...
Collins Akowe isn’t going far for the next chapter of his budding basketball career in the Philippines. The Nigerian student-athlete is making the short...
VIGAN, ILOCOS SUR — Capital1 head coach Jorge Souza de Brito will not be on the sidelines when the Solar Spikers take on Cignal...
VIGAN, ILOCOS SUR — Filipino-Americans Brooke Van Sickle, MJ Phillips, and Tia Andaya will play for Alas Pilipinas Women for the first time in...
When the lights shine brightest, Kaya-Iloilo knows how to deliver. In the dying minutes of a season-defining clash, Kaya found magic once more —...
National University was a team on a mission — tearing through the competition and capping off its dominant run with a clinical 4–2 conquest...